152 related articles for article (PubMed ID: 30630091)
1. The expression of FOXP3 and its role in human cancers.
Jia H; Qi H; Gong Z; Yang S; Ren J; Liu Y; Li MY; Chen GG
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):170-178. PubMed ID: 30630091
[TBL] [Abstract][Full Text] [Related]
2. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature.
deLeeuw RJ; Kost SE; Kakal JA; Nelson BH
Clin Cancer Res; 2012 Jun; 18(11):3022-9. PubMed ID: 22510350
[TBL] [Abstract][Full Text] [Related]
4. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors.
de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ
J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747
[TBL] [Abstract][Full Text] [Related]
6. Higher densities of Foxp3
Yeong J; Thike AA; Lim JC; Lee B; Li H; Wong SC; Hue SS; Tan PH; Iqbal J
Breast Cancer Res Treat; 2017 May; 163(1):21-35. PubMed ID: 28233108
[TBL] [Abstract][Full Text] [Related]
7. Interaction of cancer cell-derived Foxp3 and tumor microenvironment in human tongue squamous cell carcinoma.
Li K; Huang SH; Lao XM; Yang L; Liao GQ; Liang YJ
Exp Cell Res; 2018 Sep; 370(2):643-652. PubMed ID: 30040923
[TBL] [Abstract][Full Text] [Related]
8. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer.
Ziółkowska-Suchanek I; Żurawek M
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674427
[TBL] [Abstract][Full Text] [Related]
9. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
11. Complexity and diversity of FOXP3 isoforms: Novel insights into the regulation of the immune response in metastatic breast cancer.
Malla R; Adem M; Chakraborty A
Int Immunopharmacol; 2023 May; 118():110015. PubMed ID: 36931171
[TBL] [Abstract][Full Text] [Related]
12. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer.
Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB
J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.
Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L
Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
[TBL] [Abstract][Full Text] [Related]
16. [CD8 and FOXP3 expression in stromal tumor-infiltrating lymphocytes of triple-negative breast carcinomas: a clinicopathologic study].
Pan BJ; Ping GQ; Zhang WM; Wang C; Li HX; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):540-4. PubMed ID: 27510779
[TBL] [Abstract][Full Text] [Related]
17. Human FOXP3 and tumour microenvironment.
Wang J; Gong R; Zhao C; Lei K; Sun X; Ren H
Immunology; 2023 Feb; 168(2):248-255. PubMed ID: 35689826
[TBL] [Abstract][Full Text] [Related]
18. High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability.
Michel S; Benner A; Tariverdian M; Wentzensen N; Hoefler P; Pommerencke T; Grabe N; von Knebel Doeberitz M; Kloor M
Br J Cancer; 2008 Dec; 99(11):1867-73. PubMed ID: 18985040
[TBL] [Abstract][Full Text] [Related]
19. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
20. Foxp3 and IL17 expression in tumor infiltrating lymphocytes (TIL) and tumor cells - correlated or independent factors?
Vasilescu F; Arsene D; Cionca F; Comănescu M; Enache V; Iosif C; Alexandru DO; Georgescu D; Dobrea C; Bălan A; Ardeleanu C
Rom J Morphol Embryol; 2013; 54(1):43-9. PubMed ID: 23529308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]